Unity Biotechnology
A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.
All edits by James Smith
Edits on 30 Apr, 2019
James Smith
Edits made to:
Article (+7/-7 characters)
Article
On October 27, 2016 Unity Biotechnology completed their series B funding round with $116 million in funding from Bezos Expeditions (lead investor), WuXi AppTec, VenrockVenrock, Mayo Clinic, Ballie Gifford, and ARCH Venture Partners. On August 17, 2017 Unity Biotechnologies closed an additional series B funding round with $35 million in funding from several new investors including: INVUS Opportunities, Three Lakes Partners, Cycad Group, COM Investments, and Pivotal Alpha Limited.
Find more companies like Unity Biotechnology
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.